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background:  Cardiogenic shock (CS) complicating acute myocardial infarction is strongly associated with mortality. Even though there has been 
previous research regarding gender specific differences in these patients, the results so far are conflicting and, moreover, there is insufficient data 
for the contemporary era of treatment with primary percutaneous intervention (PCI).
Methods:  In the randomized Intra-aortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial 600 patients with CS complicating acute 
myocardial infarction undergoing early revascularization were assigned to therapy with IABP or no IABP. We compared sex-specific differences in 
these patients at baseline, regarding procedural characteristics and for short- and long-term outcome.
results:  Of 600 patients 187 (31%) were female. Women were significantly older than men (74 [interquartile range {IQR} 63-81] vs. 68 [IQR 
57-75] years; p<0.001), had significantly lower systolic (88 [IQR 80-101] vs. 90 [IQR 80-110] mmHg; p=0.04), and diastolic (53 [IQR 45-60] 
vs. 60 [IQR 50-70] mmHg; p<0.001) blood pressure at presentation. Diabetes mellitus and hypertension were more frequent in women, whereas 
smoking was more frequent in men. Rates of stent-implantation were lower in women (86 vs. 92%; p=0.04), 3 women and 3 men underwent bypass 
surgery. Drug-eluting stents were used less frequently in women (37 vs. 50%; p=0.006) and a patent culprit vessel after PCI was less often achieved 
in female patients (TIMI 3 flow after PCI: 77 vs. 84%; p=0.04). Women showed an unadjusted significant higher mortality within the first day after 
randomization (18 vs. 9%; p=0.004). However, there was no significant difference in acute mortality after multivariable adjustment. Also after 1, 6 
and 12 months of follow-up (women vs. men 46 vs. 42%, p=0.36; 54 vs. 47%, p=0.12; 57 vs. 50%; p=0.14, respectively) no significant differences 
unadjusted and in multivariable analysis were seen. 
conclusion:  Although women had a higher risk profile and seemed to undergo suboptimal treatment in comparison to men in CS complicating 
acute myocardial infarction, no higher mortality rates in short and long-term follow-up for women were observed. 
